Neuroplast
Neuroplast develops Neuro-Cells, a personalized medicine platform focused on neuro-regenerative treatments. The company focuses on creating uniform standards and regulations for cell-based therapies to treat neurological conditions. Their operations are centered on clinical development and providing solutions within the regenerative medicine market.
Healthtech
Biotechnology
Regenerative Medicine
Funding summary
- Total raised
- €14.0M
- Funding rounds
- 2
Investors in Neuroplast
Investors on record for Neuroplast. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Neuroplast?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors